Miguel R. Abboud

Cairo Street
Beirut, BA, Lebanon

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Developmental Trajectories of Theory of Mind in Lebanese Children Aged 3 to 11: Adaptation and Preliminary Evaluation of the Arabic Version of Battery for Children-Theory of Mind (ABC-TOM).

Developmental Trajectories of Theory of Mind in Lebanese Children Aged 3 to 11: Adaptation and Preliminary Evaluation of the Arabic Version of Battery for Children-Theory of Mind (ABC-TOM).

Journal: Developmental neuropsychology

Published: May 02, 2026

Sickle cell disease and thalassemia go to the PROm.

Sickle cell disease and thalassemia go to the PROm.

Journal: Blood advances

Published: December 15, 2025

Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource-Constrained Settings: A Cross-Sectional Study in Lebanon.

Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource-Constrained Settings: A Cross-Sectional Study in Lebanon.

Journal: Pediatric blood & cancer

Published: May 01, 2025

Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet-PHL-C1 Protocol: Experience From a Resource-Limited Country.

Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet-PHL-C1 Protocol: Experience From a Resource-Limited Country.

Journal: Cancer medicine

Published: November 28, 2024

Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial.

Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial.

Journal: The Lancet. Haematology

Published: September 24, 2024

Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.

Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.

Journal: HemaSphere

Published: July 25, 2024

Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.

Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.

Journal: The Lancet. Haematology

Published: June 19, 2024

Cerebral vasculopathy in patients with sickle cell disease and stroke: now you see it, now you don't.

Cerebral vasculopathy in patients with sickle cell disease and stroke: now you see it, now you don't.

Journal: Haematologica

Published: April 22, 2024

Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two α-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation.

Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two α-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation.

Journal: Hemoglobin

Published: April 16, 2024

Parents providing palliative care for children with cancer.

Parents providing palliative care for children with cancer.

Journal: Ecancermedicalscience

Published: March 11, 2024

A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation.

A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation.

Journal: Clinical immunology (Orlando, Fla.)

Published: July 31, 2023

Sickle cell disease care in Lebanon: resource-constrained and humanitarian crisis adaptations.

Sickle cell disease care in Lebanon: resource-constrained and humanitarian crisis adaptations.

Journal: The Lancet. Haematology

Published: February 01, 2023

Showing 1-12 of 106

Last Updated: 09/26/2026